Core Viewpoint - Intelligent Bio Solutions Inc. has been granted its sixth U.S. patent, enhancing its intellectual property portfolio and competitive position as it prepares to enter the multi-billion dollar U.S. drug screening market in 2025 [1][3]. Company Overview - Intelligent Bio Solutions Inc. is a medical technology company focused on delivering intelligent, rapid, non-invasive testing solutions, particularly through its Intelligent Fingerprinting Drug Screening System [4]. - The company aims to revolutionize portable testing via fingerprint sweat analysis, which is designed to be hygienic and cost-effective [4]. Patent Details - The newly granted U.S. Patent No. 12259385 pertains to the proprietary lateral flow test strip within the Drug Screening Cartridge, ensuring protection for all current and future products developed by the company [2]. - This patent is fundamental to the company's testing system, which utilizes lateral flow technology to detect drugs in fingerprint sweat [2]. Market Position and Strategy - The U.S. market is identified as a key focus for the company, with plans to enter this market in 2025, supported by the recent FDA 510(k) submission in December 2024 [3]. - The Intelligent Fingerprinting Drug Testing Solution addresses the growing demand for drug testing in safety-sensitive industries, providing a non-invasive alternative that supports employee well-being and compliance [3]. Target Industries - Current customer segments outside the U.S. include construction, manufacturing, engineering, transport and logistics, drug treatment organizations, and coroners [4].
Intelligent Bio Solutions Secures Key U.S. Patent, Strengthening IP Protection Ahead of Planned 2025 Market Entry